Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 5,051.44 | 4,132.55 | 3,660.27 | 2,944.63 | 2,956.44 |
| Expenses | |||||
| Material consumed | 1,528.06 | 1,273.97 | 1,177.48 | 1,044.60 | 1,035.85 |
| Manufacturing expenses | 109.79 | 97.43 | 88.44 | 70.21 | 64.13 |
| Personnel expenses | 948.27 | 806.37 | 684.45 | 582.72 | 527.46 |
| Selling expenses | - | - | 342.47 | 222.29 | 261.53 |
| Adminstrative expenses | 893.09 | 751.88 | 488.76 | 392.28 | 434.19 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 3,479.21 | 2,929.65 | 2,781.60 | 2,312.10 | 2,323.16 |
| Operating profit | 1,572.23 | 1,202.90 | 878.67 | 632.53 | 633.28 |
| Other recurring income | 9.73 | 134.75 | 6.42 | 6.67 | 2.42 |
| Adjusted PBDIT | 1,581.96 | 1,337.65 | 885.09 | 639.20 | 635.70 |
| Financial expenses | 12.77 | 25.19 | 14.87 | 2.22 | 3.09 |
| Depreciation | 152.60 | 135.67 | 105.59 | 101.76 | 82.90 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1,416.59 | 1,176.79 | 764.63 | 535.22 | 549.71 |
| Tax charges | 241.20 | 197.39 | 153.42 | 113.23 | 119.08 |
| Adjusted PAT | 1,175.39 | 979.40 | 611.21 | 421.99 | 430.63 |
| Non recurring items | -0.88 | -19.33 | -1.90 | -3.06 | -2.13 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 1,174.51 | 960.07 | 609.31 | 418.93 | 428.50 |
| Earnigs before appropriation | 2,863.44 | 2,256.56 | 1,529.07 | 1,110.52 | 1,082.34 |
| Equity dividend | - | 258.43 | 59.91 | 90.76 | 90.76 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | 33.77 | 15.50 | - | - |
| Retained earnings | 2,863.44 | 1,964.36 | 1,453.66 | 1,019.76 | 991.58 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis